Share Search
Visit the Share Search
Arecor Therape Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 1.71 | 1.64 | 4.57 | 2.40 | 1.16 |
| Operating Profit / Loss | 0.93 | -5.18 | -9.18 | -10.63 | -6.44 |
| Net Interest | 0.06 | 0.08 | 0.27 | 0.09 | -0.51 |
| Pre Tax Profit | 0.99 | -5.09 | -8.90 | -10.54 | -6.95 |
| Post Tax Profit | 0.93 | -5.16 | -8.55 | -9.26 | -6.17 |
| Profit for the Period | 0.66 | -10.24 | -8.55 | -9.26 | -6.17 |
| Equity Holders of Parent Company | 0.66 | -10.24 | -8.55 | -9.26 | -6.17 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 2.00p | -16.00p | -0.28p | -32.00p | -27.00p |
| Earnings per Share (Diluted) | 2.00p | -16.00p | -0.28p | -32.00p | -27.00p |
| Earnings per Share (Adjusted) | 2.00p | -16.00p | -0.28p | -32.00p | -27.00p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 2.00p | -31.00p | -0.28p | -32.00p | -27.00p |
| Earnings per Share (Diluted) | 2.00p | -31.00p | -0.28p | -32.00p | -27.00p |
| Earnings per Share (Adjusted) | 2.00p | -31.00p | -0.28p | -32.00p | -27.00p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 0.02 | 0.03 | 3.30 | 3.40 | 0.03 |
| Property, Plant and Equipment | 0.30 | 0.40 | 0.83 | 0.84 | 0.33 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 0.09 | 0.06 | 0.08 | 0.05 | 0.05 |
| Total Non-Current Assets | 0.40 | 0.49 | 4.21 | 4.29 | 0.41 |
| Current Assets | |||||
| Inventories | n/a | 0.48 | 0.77 | 1.13 | n/a |
| Trade and Other Receivables | 0.63 | 3.85 | 3.19 | 3.54 | 2.20 |
| Cash at Bank and in Hand | 3.00 | 3.24 | 5.09 | 4.76 | 18.32 |
| Current Asset Investments | 3.13 | 0.02 | 1.66 | 8.04 | n/a |
| Other Current Assets | 0.94 | 0.65 | 0.46 | n/a | n/a |
| Total Current Assets | 7.70 | 8.23 | 11.17 | 17.48 | 20.51 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 8.10 | 8.72 | 15.38 | 21.77 | 20.92 |
| Current Liabilities | |||||
| Borrowings | 0.10 | 0.12 | 0.12 | 0.20 | 0.13 |
| Other Current Liabilities | 1.51 | 3.13 | 5.03 | 3.53 | 2.14 |
| Total Current Liabilities | 1.61 | 3.26 | 5.15 | 3.73 | 2.27 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 0.00 | 0.11 | 0.22 | 0.09 | 0.11 |
| Provisions | 0.04 | 0.01 | 0.48 | 0.50 | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | 0.04 | 0.12 | 0.70 | 0.58 | 0.11 |
| Net Assets | 6.45 | 5.35 | 9.53 | 17.45 | 18.55 |
| Capital and Reserves | |||||
| Share Capital | 0.38 | 0.38 | 0.31 | 0.31 | 0.28 |
| Share Premium Account | 34.68 | 34.68 | 28.98 | 28.98 | 23.35 |
| Other Reserves | 15.69 | 15.24 | 14.97 | 14.35 | 11.97 |
| Retained Earnings | -44.29 | -44.96 | -34.72 | -26.18 | -17.05 |
| Shareholders Funds | 6.45 | 5.35 | 9.53 | 17.45 | 18.55 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 6.45 | 5.35 | 9.53 | 17.45 | 18.55 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | 54.38% | -315.03% | -200.63% | -442.36% | -556.04% |
| Return on Capital Employed | 14.18% | -93.19% | -130.09% | -71.65% | -34.34% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | 40.30 | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 17.05p | 14.08p | 16.50p | 37.22p | 49.05p |